Bodisen Biotech Inc (BBCZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 8,056 | 7,685 | 6,595 | 5,217 | 7,595 |
| Cost of Goods | 6,942 | 5,609 | 5,742 | 3,858 | 7,189 |
| Gross Profit | 1,114 | 2,076 | 853 | 1,359 | 405 |
| Operating Expenses | 15,587 | 4,946 | 5,739 | 3,175 | 7,722 |
| Operating Income | -13,531 | -2,261 | -4,144 | -957 | -7,127 |
| Interest Expense | 84 | 146 | 93 | 0 | 0 |
| Other Income | -2,754 | 96 | 67 | 1,328 | 166 |
| Pre-tax Income | -16,370 | -2,310 | -4,170 | 371 | -6,961 |
| Income Tax | N/A | N/A | N/A | N/A | -42 |
| Net Income Continuous | -16,370 | -2,310 | -4,170 | 371 | -6,919 |
| Net Income | $-16,370 | $-2,310 | $-4,170 | $371 | $-6,919 |
| EPS Basic Total Ops | -0.76 | -0.11 | -0.22 | 0.02 | -0.37 |
| EPS Basic Continuous Ops | -0.76 | -0.11 | -0.22 | 0.02 | -0.37 |
| EPS Diluted Total Ops | -0.76 | -0.11 | -0.22 | 0.02 | -0.37 |
| EPS Diluted Continuous Ops | -0.76 | -0.11 | -0.22 | 0.02 | -0.37 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.11 | -0.22 | -0.04 | -0.32 |
| EBITDA(a) | $-11,836 | $-428 | $-3,220 | $-138 | $-6,608 |